Advocacy for better metabolic monitoring after antipsychotic initiation: based on data from a French health insurance database.

: Nearly 3% of the population is treated by antipsychotic. The aim of this study was to assess the conformity of monitoring with guidelines to prevent Metabolic Syndrome. : The analysis was conducted using SNIIRAM data (2013 to 2017) on a cohort of patients who received at least eight antipsychotic dispensings in the first year.

Influence of socioeconomic status on antipsychotic prescriptions among youth in France.

Background: Recent studies analysing the trends in antipsychotic (AP) prescriptions for children and adolescents have raised concerns regarding the influence of socioeconomic status. Previous findings have also shown variable prescription rates for first-generation (FG) and second-generation (SG) APs.

Method: Our objectives were to assess the proportion of patients from low-income families receiving APs and the most commonly prescribed APs in France.